OncoImmunology
Volume 10, 2021 - Issue 1
Research Article
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice
Jolien M.R. Van der Meera Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands
https://orcid.org/0000-0001-9288-1500View further author information
https://orcid.org/0000-0001-9288-1500View further author information, Paul K.J.D. de Jongea Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-1228-5002View further author information
https://orcid.org/0000-0002-1228-5002View further author information, Anniek B. van der Waarta Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0001-5986-3060View further author information
https://orcid.org/0000-0001-5986-3060View further author information, Alexander C. Geerlingsa Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-9146-8164View further author information
https://orcid.org/0000-0002-9146-8164View further author information, , Jolanda Brummelmana Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0003-3581-4816View further author information
https://orcid.org/0000-0003-3581-4816View further author information, , , Ralph J.A. Maasa Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-3185-5226View further author information
https://orcid.org/0000-0002-3185-5226View further author information, Nicolaas P.M. Schaapb Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlandshttps://orcid.org/0000-0001-7696-4752View further author information
https://orcid.org/0000-0001-7696-4752View further author information, Janneke S. Hoogstad-van Everta Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands;c Department of Obstetrics and Gynecology, Amphia Hospital, The Netherlandshttps://orcid.org/0000-0001-9838-0977View further author information
https://orcid.org/0000-0001-9838-0977View further author information, Petronella B. Ottevangerd Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlandshttps://orcid.org/0000-0001-8209-487XView further author information
https://orcid.org/0000-0001-8209-487XView further author information, Joop H. Jansena Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0001-9459-568XView further author information
https://orcid.org/0000-0001-9459-568XView further author information, Willemijn Hoboa Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-8206-8185View further author information
https://orcid.org/0000-0002-8206-8185View further author information & Harry Dolstraa Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center/Radboud Institute for Molecular Life Sciences, Nijmegen, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-3998-687XView further author information
https://orcid.org/0000-0002-3998-687XView further author information show all